Seaport Therapeutics, Inc.(SPTX:US)
Market Cap$945.49M
Key Metrics
Price$17.83
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$52.91M
Total Assets$227.67M
Net Assets-$115.62M
Total Debt$5.34M
Key Metrics
Price$17.83
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$52.91M
Total Assets$227.67M
Net Assets-$115.62M
Total Debt$5.34M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $0 | $0 |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $27.54M | $16.19M | |
| Research and Development | $21.43M | $10.53M |
| Selling, General, and Administrative | $6.11M | $5.65M |
| Other Operating Expenses | - | - |
Operating Income | -$27.54M | -$16.19M |
| $2.65M | $3.09M | |
| Non-Operating Interest Income | $2.13M | $3.1M |
| Non-Operating Interest Expense | - | - |
| Other Income/Expense | $521K | -$9K |
Income Before Tax | -$24.89M | -$13.09M |
Income Tax | $519K | $31K |
Net Income | -$25.41M | -$13.13M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$25.41M | -$13.13M |
Shares Outstanding (Basic) | 53.03M | 38.65M |
Shares Outstanding (Diluted) | 53.03M | 38.65M |
EPS (Basic) | -$0.48 | -$0.34 |
EPS (Diluted) | -$0.48 | -$0.34 |
EBIT | -$27.54M | -$16.19M |
EBITDA | -$27.19M | -$15.87M |